ACM
ELAT

Advent Capital Management’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Advent Capital Management’s Portfolio ELAT Stock Details ELAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-133,023
Closed -$4.27M – 260
2022
Q2 		$4.27M Sell
133,023
-337,405
-72% -$12.7M 0.08% 173
2022
Q1 		$19.4M Buy
470,428
+8,000
+2% +$335K 0.31% 105
2021
Q4 		$20.6M Sell
462,428
-110,560
-19% -$5.32M 0.35% 93
2021
Q3 		$28.6M Buy
572,988
+85,487
+18% +$4.45M 0.53% 72
2021
Q2 		$26.1M Buy
487,501
+134,951
+38% +$6.78M 0.51% 70
2021
Q1 		$16.1M Buy
352,550
+124,075
+54% +$5.96M 0.35% 91
2020
Q4 		$10.9M Buy
228,475
+71,749
+46% +$3.43M 0.23% 105
2020
Q3 		$7M Sell
156,726
-97,924
-38% -$4.13M 0.15% 113
2020
Q2 		$9.89M Buy
254,650
+211,200
+486% +$8.54M 0.23% 101
2020
Q1 		$1.81M Buy
+43,450
New +$2.08M 0.04% 165

Other funds holding ELAT

VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
Elequin Capital New York $1.19B AUM 16.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Advent Capital Management's ELAT Position: Q3 2022 in Review

Advent Capital Management sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q3 2022, closing a stake of 133,023 shares — an estimated $4.27M sold.

Advent Capital Management first reported a position in ELAT in Q1 2020 and held it in 10 quarters. The position peaked at $28.6M in Q3 2021. 31 funds tracked by Wall St. Rank hold ELAT as of Q3 2022.

  • Advent Capital Management reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q3 2022 after selling out during the quarter.
  • Advent Capital Management sold 133,023 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q3 2022, an estimated $4.27M.
  • Advent Capital Management first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 10 quarters.
  • Advent Capital Management's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $28.6M in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q3 2022.

Based on Advent Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.